Schedule 13G ownership disclosure
Celator Pharmaceuticals Inc
Security class unavailable · CUSIP: 15089R102
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-004722
- Form type
- SC 13G
- Filer
- Celator Pharmaceuticals Inc
- CIK
- CIK 1327467
- Filed
- Jan 30, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership